Financial News

Mydecine Innovations Group Announces Launch of Mindleap Version 2.0

Products You May Like

The digital well being platform will present the infrastructure to assist the acutely aware and reliable adoption of psychedelics

DENVER, July 13, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Firm’), an rising biopharma and life sciences firm dedicated to the analysis, improvement, and acceptance of different nature-sourced medication for mainstream use is happy to announce that its subsidiary Mindleap Well being (“Mindleap”), is launching the two.0 model of its virtual health platform on July 30, 2021 (see Mindleap.com), which offers the infrastructure to assist the acutely aware and reliable adoption of psychedelics into the broader classes of psychological well being and inside wellness.

“We’re offering a platform that may assist remodel the lives of tens of millions of individuals,” mentioned Mindleap Interim CEO & Technical Director William Cook dinner. “Our goal is to carry acutely aware and reliable assist for folks on their day by day mental-health journey whereas additionally supporting life-changing therapeutic experiences.”

Mindleap is designed to assist customers by way of quite a few complementary options, together with a media library that comprises guided meditations, sound journeys, and academic content material about inside wellness and psychedelic medicines. Mindleap’s media content material is developed in partnership with world-class researchers and practitioners who examine and observe numerous facets of psychedelic medicines and coverings, psychological well being, and neuroscience. Among the friends featured on Mindleap 2.0 content material embody main researchers equivalent to David Erritzoe, MD, Ph.D. from Imperial School of London, John Cline, Ph.D. from Yale, in addition to Gregory Wells, PhD, and Marcela Ot’alora G. from MAPS.

Mindleap 2.0 additionally incorporates a give attention to the neighborhood that enables customers to get to know and be taught from psychological well being specialists by way of media and written posts. As soon as customers are prepared, they will schedule and attend encrypted video assist classes by way of the platform and obtain steering from psychedelic integration or inside wellness specialists. Customers can monitor and log numerous facets of their inside wellness by way of the up to date non-public well being journal. Moreover, they’ve the choice to briefly share their well being journal with a specialist throughout a non-public video assist name, to assist specialists develop a greater understanding of how they’re doing.

“The platform offers the optimum neighborhood area for customers to develop belief in and join with assist professionals,” mentioned Nicholas Martin, Mindleap’s Director of Specialists & Neighborhood. “Customers will have the ability to join with integration specialists who’ve demonstrated expertise and coaching from psychedelic integration coaching packages.”

Mindleap can be being designed to assist affected person care and monitoring that helps medical trials, together with these being run by Mindleap’s mum or dad firm, Mydecine Improvements Group. Collectively, Mindleap’s content material library, well being journal, neighborhood platform, video assist classes, and observe administration portal make it a complicated bundled resolution that’s paving the way in which for the way forward for psychological well being.

About Mydecine Improvements Group
Mydecine Improvements Group™ (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) is an rising biotech and life sciences firm devoted to creating and commercializing progressive options for treating psychological well being issues and enhancing vitality. The corporate’s world-renowned medical and scientific advisory board is constructing out a sturdy R&D pipeline of nature-sourced psychedelic-assisted therapeutics, novel compounds, remedy protocols, and distinctive supply techniques. Mydecine has unique entry to a full cGMP licensed pharmaceutical manufacturing facility with the flexibility to import/export, domesticate, extract/isolate, and analyze energetic mushroom compounds with full authorities approval by Well being Canada. Mydecine additionally operates out of a state-of-the-art mycology lab in Denver, CO to give attention to genetic analysis for scaling business cultivation of uncommon (non-psychedelic) medicinal mushrooms.

On the coronary heart of Mydecine’s core philosophy is that psychedelic-assisted psychotherapy will proceed to achieve acceptance within the medical neighborhood with lots of the world’s greatest accredited analysis organizations demonstrating its exceptional medical effectiveness. Mydecine acknowledges the duty related to psychedelic-assisted remedy and can proceed to place itself as a long-term chief throughout the spectrum of medical trials, analysis, know-how, and international provide. Mydecine has additionally efficiently accomplished a number of acquisitions since its inception.

Be taught extra at: https://www.mydecine.com and https://mindleap.com and comply with us on Facebook, Twitter, and Instagram.

About Mindleap Well being
Mindleap Well being Inc., a wholly-owned subsidiary of Mydecine, is a digital healthcare firm that provides know-how options that enable folks to enhance their psychological well being and wellbeing. Mindleap is a digital well being platform that gives our customers with inside wellness assets to help them of their day by day mental-health journey. Mindleap incorporates a neighborhood of pros, a non-public well being journal, and an ever-expanding content material library that features meditations and psychoeducation supplies from consultants in psychological well being. Mindleap offers the area for customers to videoconference with professionals who can assist them in psychedelic integration, in addition to their inside wellness journeys extra broadly. The Mindleap infrastructure is designed to foster the acutely aware and reliable adoption of psychedelics right into a extensively accepted method to psychological well being and inside wellness.

For extra data, please contact:

Media Contacts
Anne Donohoe / Nick Opich
KCSA Strategic Communications
myco@kcsa.com

1-212-896-1265 / 1-212-896-1206

Investor Contacts
Charles Lee, Investor Relations
corp@mydecineinc.com

1-720-277-9879

Allison Soss / Erika Kay
KCSA Strategic Communications
myco@kcsa.com

1-212-896-1267

On behalf of the Board of Administrators:
Joshua Bartch, Chief Government Officer
contact@mydecineinc.com

For additional details about Mydecine Improvements Group, Inc., please go to the Firm’s profile on SEDAR at www.sedar.com or go to the Firm’s web site atwww.mydecine.com.

This information launch comprises forward-looking data inside the that means of Canadian securities legal guidelines relating to the Firm and its enterprise, which relate to future occasions or future efficiency and mirror administration’s present expectations and assumptions. Usually however not all the time, forward-looking data could be recognized by way of phrases equivalent to “anticipate”, “intends”, “anticipated”, “believes” or variations (together with damaging variations) of such phrases and phrases, or state that sure actions, occasions or outcomes “might”, “might”, “would” or “will” be taken, happen or be achieved. Such forward-looking statements mirror administration’s present beliefs and are based mostly on assumptions made by and data at the moment out there to the Firm. Readers are cautioned that these forward-looking statements are neither guarantees nor ensures, and are topic to dangers and uncertainties that will trigger future outcomes to vary materially from these anticipated together with, with out limitation, dangers relating to the COVID-19 pandemic, the supply and continuity of financing, the flexibility of the Firm to adequately shield and implement its mental property, the Firm’s potential to carry its merchandise to business manufacturing, continued development of the worldwide adaptive pathway medication, pure well being merchandise and digital well being industries, and the dangers offered by the extremely regulated and aggressive market in regards to the improvement, manufacturing, sale and use of the Firm’s merchandise. Though the Firm has tried to establish essential components that might trigger precise outcomes to vary materially from these contained in forward-looking data, there could also be different components that trigger outcomes to not be as anticipated, estimated or meant. There could be no assurance that such data will show to be correct, as precise outcomes and future occasions might differ materially from these anticipated in such data. These forward-looking statements are made as of the date hereof and the Firm doesn’t assume any obligation to replace or revise them to mirror new occasions or circumstances save as required beneath relevant securities laws.

Primary Logo

Products You May Like